{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:05:26Z","timestamp":1790622326362,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.neulet.2011.08.044","type":"journal-article","created":{"date-parts":[[2011,8,29]],"date-time":"2011-08-29T19:31:30Z","timestamp":1314646290000},"page":"240-243","source":"Crossref","is-referenced-by-count":7,"title":["In vivo 5-HT6 receptor occupancy by antipsychotic drugs in the rat brain"],"prefix":"10.1016","volume":"503","author":[{"given":"Kazufumi","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten L.","family":"Searle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabina","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiu-Cheong","family":"Aw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward R.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Richard","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2011.08.044_bib0005","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1176\/appi.ajp.157.4.549","article-title":"Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates","volume":"157","author":"Bilder","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2011.08.044_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/15622970701432551","article-title":"Effect of donepezil added to atypical antipsychotics on cognition in patients with schizophrenia: an open-label trial","volume":"10","author":"Chung","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2011.08.044_bib0015","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0893-133X(01)00265-2","article-title":"The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus","volume":"25","author":"Dawson","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2011.08.044_bib0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejphar.2008.04.039","article-title":"Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G\u03b1s","volume":"588","author":"Dupuis","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2011.08.044_bib0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.npp.1300332","article-title":"The 5-HT6 receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats","volume":"29","author":"Foley","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2011.08.044_bib0030","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuropharm.2008.06.061","article-title":"An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function","volume":"55","author":"Fone","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2011.08.044_bib0035","first-page":"580","article-title":"Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance","volume":"161","author":"Fuller","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2011.08.044_bib0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bmcl.2006.10.036","article-title":"Studies towards the identification of a new generation of atypical antipsychotic agents","volume":"17","author":"Garzya","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neulet.2011.08.044_bib0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-8993(96)01224-3","article-title":"Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system","volume":"746","author":"Gerard","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2011.08.044_bib0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1098-2396(199607)23:3<164::AID-SYN5>3.0.CO;2-6","article-title":"Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats","volume":"23","author":"Gerard","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.neulet.2011.08.044_bib0055","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF03401577","article-title":"Clozapine: selective labeling of sites resembling 5HT6 serotonin receptors may reflect psychoactive profile","volume":"1","author":"Glatt","year":"1995","journal-title":"Mol. Med."},{"key":"10.1016\/j.neulet.2011.08.044_bib0060","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1037\/0894-4105.12.3.426","article-title":"Neurocognitive deficit in schizophrenia: a quantitative review of the evidence","volume":"12","author":"Heinrichs","year":"1998","journal-title":"Neuropsychology"},{"key":"10.1016\/j.neulet.2011.08.044_bib0065","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1124\/mol.64.6.1295","article-title":"Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling","volume":"64","author":"Hirst","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2011.08.044_bib0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2006.09.049","article-title":"SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models","volume":"553","author":"Hirst","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2011.08.044_bib0075","unstructured":"A.J. Hunter, Neurology CEDD. Focus on Alzheimer's disease, GlaxoSmithKline, http:\/\/www.gsk.com\/investors\/presentations\/2007\/neurosciences-seminar-dec07\/jackie-hunter.pdf, 2007."},{"key":"10.1016\/j.neulet.2011.08.044_bib0080","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s002130100790","article-title":"Drug-induced receptor occupancy: substantial differences in measurements made in vivo vs ex vivo","volume":"157","author":"Kapur","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2011.08.044_bib0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejphar.2008.06.063","article-title":"Validation of a rat in vivo [3H]M100907 binding assay to determine a translatable measure of 5-HT(2A) receptor occupancy","volume":"591","author":"Knauer","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2011.08.044_bib0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuropharm.2006.03.020","article-title":"Comparison of in vivo and ex vivo [3H]flumazenil binding assays to determine occupancy at the benzodiazepine binding site of rat brain GABAA receptors","volume":"51","author":"Li","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2011.08.044_bib0095","first-page":"S7","article-title":"Radiolabelling and in vivo evaluation of [11C]GSK215083 as a potential 5-HT6 PET radioligand in the porcine brain","volume":"48","author":"Martarello","year":"2005","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.neulet.2011.08.044_bib0100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-200746050-00001","article-title":"Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response","volume":"46","author":"Mauri","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.neulet.2011.08.044_bib0105","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pharmthera.2005.05.001","article-title":"5-HT6 receptors: a novel target for cognitive enhancement","volume":"108","author":"Mitchell","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neulet.2011.08.044_bib0110","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tips.2008.06.007","article-title":"Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions","volume":"29","author":"Millan","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"Suppl. B","key":"10.1016\/j.neulet.2011.08.044_bib0115","first-page":"117","article-title":"Plasma clozapine concentrations as a predictor of clinical response: a follow-up study","volume":"55","author":"Miller","year":"1994","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. B","key":"10.1016\/j.neulet.2011.08.044_bib0120","first-page":"133","article-title":"Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia","volume":"55","author":"Potkin","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neulet.2011.08.044_bib0125","first-page":"104","article-title":"The therapeutic potential of 5-HT6 receptor antagonists","volume":"2","author":"Reavill","year":"2001","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.neulet.2011.08.044_bib0130","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/jm021085c","article-title":"Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist","volume":"46","author":"Riemer","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2011.08.044_bib0135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s002130100840","article-title":"5-HT6 receptor antagonists enhance retention of a water maze task in the rat","volume":"158","author":"Rogers","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2011.08.044_bib0140","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","article-title":"Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors","volume":"268","author":"Roth","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2011.08.044_bib0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.euroneuro.2006.06.009","article-title":"Effects of the novel 5-HT6 receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating","volume":"17","author":"Schreiber","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2011.08.044_bib0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(93)91535-Z","article-title":"Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography","volume":"631","author":"Schotte","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2011.08.044_bib0155","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0893-133X(01)00400-6","article-title":"Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat","volume":"26","author":"Shirazi-Southall","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2011.08.044_bib0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0893-133X(94)00064-7","article-title":"Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy","volume":"12","author":"Sumiyoshi","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2011.08.044_bib0165","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0022-3565(25)39339-0","article-title":"Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors","volume":"266","author":"Stockmeier","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2011.08.044_bib0170","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.lfs.2007.01.038","article-title":"Brain neurotransmitter receptor-binding characteristics in rats after oral administration of haloperidol, risperidone and olanzapine","volume":"80","author":"Uchida","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.neulet.2011.08.044_bib0175","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0306-4522(94)00439-C","article-title":"Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry","volume":"64","author":"Ward","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2011.08.044_bib0180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1517\/14656566.1.1.121","article-title":"The pharmacology of donepezil: a new treatment of Alzheimer's disease","volume":"1","author":"Wilkinson","year":"1999","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.neulet.2011.08.044_bib0185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S146114570500516X","article-title":"A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia","volume":"8","author":"Woodward","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2011.08.044_bib0190","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0028-3908(01)00056-9","article-title":"A role of 5-ht6 receptors in retention of spatial learning in the Morris water maze","volume":"41","author":"Woolley","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2011.08.044_bib0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568007043482561","article-title":"5-ht6 receptors","volume":"3","author":"Woolley","year":"2004","journal-title":"Curr. Drug. Targets CNS Neurol. Disord."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394011012298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394011012298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T11:27:21Z","timestamp":1741519641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394011012298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0304394011012298"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2011.08.044","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}